Bisphosphonate-related osteonecrosis of the jaw caused by implant: a case report

doi:10.7518/hxkq.2020.04.019

Abstract

Abstract:

Osteonecrosis of the jaw could occur after intake of bisphosphonate drugs, which are widely used to treat osteoporosis and bone metastasis of malignant tumors. This effect has aroused concern among dentists. In this paper, a case of bisphosphonate-related osteonecrosis caused by implant is reported, and the pathogenesis, diagnosis, prevention, and treatment of bisphosphonate drug-induced osteonecrosis are described through a literature review. The effects of bisphosphonate drug treatment on dental implants are also discussed.

Key words: bisphosphonate, osteonecrosis, jaw, implant

CLC Number:

R782.3

Wu Pingfan, Li Yu, Lei Zhenge, Chen Linlin. Bisphosphonate-related osteonecrosis of the jaw caused by implant: a case report[J]. West China Journal of Stomatology, 2020, 38(4): 460-463.

Figures/Tables 4

References 21

[1]	Yamazaki T, Takahashi K, Bessho K. Recent clinical evidence in bisphosphonate-related osteomyelitis of the jaw: focus on risk, prevention and treatment[J]. Rev Recent Clin Trials, 2014,9(1):37-52.
[2]	Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic[J]. J Oral Maxillofac Surg, 2003,61(9):1115-1117. URL pmid: 12966493
[3]	Walter C, Sagheb K, Bitzer J, et al. Analysis of reasons for osteonecrosis of the jaws[J]. Clin Oral Investig, 2014,18(9):2221-2226. doi: 10.1007/s00784-014-1205-6 URL pmid: 24535075
[4]	Migliorati CA, Casiglia J, Epstein J, et al. Managing the care of patients with bisphosphonate-associated osteonecrosis[J]. J Am Dent Assoc, 2005,136(12):1658-1668. URL pmid: 16383047
[5]	Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century[J]. J Oral Maxillofac Surg, 2005,63(5):682-689. URL pmid: 15883944
[6]	Boff RC, Salum FG, Figueiredo MA, et al. Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws[J]. Arch Oral Biol, 2014,59(8):790-799. doi: 10.1016/j.archoralbio.2014.05.002 URL pmid: 24859766
[7]	Walter C, Pabst A, Ziebart T, et al. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro[J]. Oral Dis, 2011,17(2):194-199. URL pmid: 20796232
[8]	Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats[J]. Cancer Res, 2002,62(22):6538-6544.
[9]	郎淼杰, 周稚辉, 毛静静, 等. 唑来膦酸对血管内皮细胞损伤的影响[J]. 中华口腔医学杂志, 2015,50(7):399-402.
	Lang MJ, Zhou ZH, Mao JJ , et al. The influence of zoledronic acid on vascular endothelial cell[J]. Chin J Stomatol, 2015,50(7):399-402.
[10]	Lo JC, O’Ryan FS, Gordon NP, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure[J]. J Oral Maxillofac Surg, 2010,68(2):243-253. doi: 10.1016/j.joms.2009.03.050 URL pmid: 19772941
[11]	Bianchi SD, Scoletta M, Cassione FB, et al. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007,104(2):249-258. doi: 10.1016/j.tripleo.2007.01.040 URL pmid: 17560140
[12]	Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws: 2009 update[J]. J Oral Maxillofac Surg, 2009,67(5 Suppl):2-12. URL pmid: 19371809
[13]	潘剑, 王杞章, 刘济远. 双膦酸盐相关性颌骨坏死[J]. 华西口腔医学杂志, 2017,35(1):29-36.
	Pan J, Wang QZ, Liu JY . Research progress on bisphosphonate-related osteonecrosis of the jaws[J]. West China J Stomatol, 2017,35(1):29-36.
[14]	Freiberger JJ, Padilla-Burgos R, McGraw T, et al. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics[J]. J Oral Maxillofac Surg, 2012,70(7):1573-1583. URL pmid: 22698292
[15]	Curi MM, Cossolin GS, Koga DH, et al. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases[J]. J Oral Maxillofac Surg, 2007,65(2):349-355. doi: 10.1016/j.joms.2005.12.051 URL pmid: 17236949
[16]	Agrillo A, Ungari C, Filiaci F, et al. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis[J]. J Craniofac Surg, 2007,18(5):1071-1075. URL pmid: 17912085
[17]	Duarte PM, de Vasconcelos Gurgel BC, Sallum AW, et al. Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats[J]. J Periodontol, 2005,76(1):107-114. doi: 10.1902/jop.2005.76.1.107 URL
[18]	Yoshinari M, Oda Y, Inoue T, et al. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants[J]. Biomaterials, 2002,23(14):2879-2885. doi: 10.1016/S0142-9612(01)00415-X URL
[19]	Degidi M, Piattelli A. Immediately loaded bar-connected implants with an anodized surface inserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: a case report with a 12-month follow-up[J]. Clin Implant Dent Relat Res, 2003,5(4):269-272. URL pmid: 15127998
[20]	Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report[J]. Int J Oral Maxillofac Implants, 1995,10(1):74-78. URL pmid: 7615320
[21]	李剑平, 张望群, 于静, 等. 实验性骨质疏松对种植体周自体骨移植愈合影响的研究[J]. 华西口腔医学杂志, 2010,28(4):435-438.
	Li JP, Zhang WQ, Yu J , et al. The effect of experimental osteoporosis on bone healing of autologous iliac crest graft around implants[J]. West China J Stomatol, 2010,28(4):435-438.